sacituzumab govitecan
gilead sciences
['mbc', 'sacituzumab govitecan', 'tropics02']
#tropics02 phase 3 trial presented by at #asco22: sacituzumab govitecan improved pfs and orr compared with chemo in pretreated hr+ mbc patients. os immature, but showing a positive trend. higher rate of g 3 aes with sacituzumab. 
MD, Research Fellow @DanaFarber | @harvardmed | @IEOufficiale | @LaStatale. Interested in breast oncology, HER2, ADCs & good music. Coffee expert.